Roger Adsett
Chief Operating Officer bij INSMED INCORPORATED
Vermogen: 4 M $ op 31-03-2024
Profiel
Roger Adsett is currently an Independent Director at Landos Biopharma, Inc. since 2022.
He is also currently serving as the Chief Operating Officer at Insmed, Inc. since 2016.
Previously, he worked at AstraZeneca PLC as the Director of Marketing & Brand from 1994 to 2005.
He also held the position of Marketing Director at AstraZeneca R & D Lund and Nexium, Inc. From 2005 to 2016, he worked at Shire Plc as the SVP and Head of Gastrointestinal & Internal Medicine.
Mr. Adsett completed his undergraduate degree at Bucknell University and holds an MBA from The Wharton School of the University of Pennsylvania.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
INSMED INCORPORATED
0.10% | 12-01-2024 | 148 559 ( 0.10% ) | 4 M $ | 31-03-2024 |
LANDOS BIOPHARMA, INC.
-.--% | 23-05-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Roger Adsett
| Bedrijven | Functie | Begin |
|---|---|---|
| INSMED INCORPORATED | Chief Operating Officer | 14-11-2019 |
| LANDOS BIOPHARMA, INC. | Director/Board Member | 08-03-2022 |
Eerdere bekende functies van Roger Adsett
| Bedrijven | Functie | Einde |
|---|---|---|
| SHIRE | Corporate Officer/Principal | 01-09-2016 |
| ASTRAZENECA PLC | Sales & Marketing | 01-10-2005 |
| Nexium, Inc. | Sales & Marketing | - |
| AstraZeneca R & D Lund | Sales & Marketing | - |
Opleiding van Roger Adsett
| Bucknell University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| INSMED INCORPORATED | Health Technology |
| LANDOS BIOPHARMA, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
| Nexium, Inc. | Finance |
| AstraZeneca R & D Lund |
